Suggestions
Ray Abaskharon
Life Sciences | New Product Commercialization | Consulting | Market Research
Ray Abaskharon is a highly experienced professional with a background in Market Research, Marketing, Sales Force, and Consulting.
He studied at Rutgers University and has held various key positions in reputable organizations.
Ray Abaskharon was the Founder of Veritas est, Vice President at ThinkGen, and contributed to HIV Franchise Market Research at Merck.
Additionally, he has served as a Business Associate Consultant and Business Associate at ZS Associates, showcasing his versatile skill set and expertise in the industry.
Highlights
69 inches... 69 inches of fight. One more inch than me...
...and somehow, Nate Robinson became a 3 time dunk champion, National Basketball Association (NBA) veteran, and one of the most admired players on the New York Knicks, Inc.
But how could someone with a serious condition not be brought through a standard patient process toward a life saving treatment?
I watched him routinely as Knicks fan. Was inspired by every time I saw him sore over a defender a foot taller and dunk the ball.
But as a professional in the #lifesciences industry, I was shocked by an ESPN story about him today (link below).
How could an on-court warrior feel so defeated by a medical condition (and yes I understand a very intensive treatment process, but still)?
How could someone so well resourced not clearly know if he was actually on a kidney transplant wait-list?
THIS is why patient journey is so critical to me and our team at Veritas est.
Striving for better health outcomes.
For people to not be lost in the system.
So that people have access to life saving and life changing treatments.
As much as I rooted against the Miami HEAT and Alonzo Mourning on the court, I'm so glad that he shared his experience with Robinson, that Robinson found a patient advocate, and that others in the NBA surrounded him.
I'm looking forward to the day Nate Robinson wins this battle too.
"Health economists and public-health researchers have said the U.S. could improve its infant-mortality rate by following the examples of other developed countries with comparatively low infant-mortality rates, where public health authorities devote more attention to mothers and babies.
In many European countries, for example, nurses or other health professionals visit parents and their babies at home."
As a father, a healthcare consultant, and simply a person, this is not the kind of statistic I ever want to wake up to again. We need to do better. I'm committed to improving this every chance I get to do work in #womenshealth and #pediatrics
#healthcare #realworldevidence #pharmaceutical #marketresearch #pharmamarketing
